Menstrual Cycle Phases for Triglyceride Levels

Overseen By Pascal Imbeault, PhD

Age: 18 - 65

Sex: Female

Trial Phase: Academic

Sponsor: University of Ottawa

Must not be taking: Hypolipemics, Hormonal contraceptives, Antidepressants, Anticoagulants

Disqualifiers: Chronic disease, Smoking, Pregnancy, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 3

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to investigate the effect of menstrual cycle phases on postprandial triglyceride concentrations in healthy young female adults. The main question it aims to answer is: do postprandial triglyceride concentrations differ between the follicular and luteal phases of the menstrual cycle?

Participants will: visit the laboratory for a preliminary screening session to assess eligibility, and undergo two experimental sessions consisting of six hours of seated rest following the consumption of a high-fat meal (one session conducted in the early follicular phase, and one session conducted in the mid-luteal phase of the menstrual cycle).

Are You a Good Fit for This Trial?

Inclusion Criteria

I can speak English or French.

I am able to understand and agree to participate in the study.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 session

1 visit (in-person)

Early Follicular Phase

Participants undergo a 6-hour experimental session following the consumption of a high-fat meal during the early follicular phase of the menstrual cycle

6 hours

1 visit (in-person)

Mid-Luteal Phase

Participants undergo a 6-hour experimental session following the consumption of a high-fat meal during the mid-luteal phase of the menstrual cycle

6 hours

1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the experimental sessions

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Early Follicular Phase
• Mid-Luteal Phase

How Is the Trial Designed?

Group I: Mid-Luteal Phase Experimental Treatment 1 Intervention

Group II: Early Follicular Phase Experimental Treatment 1 Intervention

Who Is Running the Clinical Trial?

University of Ottawa

Lead Sponsor

Trials

231

Recruited

267,000+

Natural Sciences and Engineering Research Council, Canada

Collaborator

Trials

63

Recruited

3,000+

Hopital Montfort

Collaborator

Trials

15

Recruited

5,000+

Institut du Savoir Montfort

Collaborator

Trials

2

Recruited

210+